BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36928924)

  • 1. Pleckstrin-2-promoted PPM1B degradation plays an important role in transforming growth factor-β-induced breast cancer cell invasion and metastasis.
    Du L; Li J; Tian Y; Feng R
    Cancer Sci; 2023 Jun; 114(6):2429-2444. PubMed ID: 36928924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLEK2 mediates metastasis and vascular invasion via the ubiquitin-dependent degradation of SHIP2 in non-small cell lung cancer.
    Wu DM; Deng SH; Zhou J; Han R; Liu T; Zhang T; Li J; Chen JP; Xu Y
    Int J Cancer; 2020 May; 146(9):2563-2575. PubMed ID: 31498891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β-induced PLEK2 promotes metastasis and chemoresistance in oesophageal squamous cell carcinoma by regulating LCN2.
    Wang F; Zhang C; Cheng H; Liu C; Lu Z; Zheng S; Wang S; Sun N; He J
    Cell Death Dis; 2021 Oct; 12(10):901. PubMed ID: 34601488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein phosphatase 1B dephosphorylates Rho guanine nucleotide dissociation inhibitor 1 and suppresses cancer cell migration and invasion.
    Cho HJ; Kim JT; Lee SJ; Hwang YS; Park SY; Kim BY; Yoo J; Hong KS; Min JK; Lee CH; Lim JS; Yoon SR; Choi I; Choe YK; Lee HG
    Cancer Lett; 2018 Mar; 417():141-151. PubMed ID: 29307615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway.
    Shen H; He M; Lin R; Zhan M; Xu S; Huang X; Xu C; Chen W; Yao Y; Mohan M; Wang J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):247. PubMed ID: 31182136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNF12 is regulated by AKT phosphorylation and promotes TGF-β driven breast cancer metastasis.
    Huang Y; Liu S; Shan M; Hagenaars SC; Mesker WE; Cohen D; Wang L; Zheng Z; Devilee P; Tollenaar RAEM; Li Z; Song Y; Zhang L; Li D; Ten Dijke P
    Cell Death Dis; 2022 Jan; 13(1):44. PubMed ID: 35013159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis.
    Xue J; Lin X; Chiu WT; Chen YH; Yu G; Liu M; Feng XH; Sawaya R; Medema RH; Hung MC; Huang S
    J Clin Invest; 2014 Feb; 124(2):564-79. PubMed ID: 24382352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer.
    Juang YL; Jeng YM; Chen CL; Lien HC
    Mol Carcinog; 2016 Dec; 55(12):2247-2259. PubMed ID: 26824226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK/Sp1 signaling pathways.
    Zhao Y; Ma J; Fan Y; Wang Z; Tian R; Ji W; Zhang F; Niu R
    Mol Oncol; 2018 Mar; 12(3):305-321. PubMed ID: 29215776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pin1 promotes transforming growth factor-beta-induced migration and invasion.
    Matsuura I; Chiang KN; Lai CY; He D; Wang G; Ramkumar R; Uchida T; Ryo A; Lu K; Liu F
    J Biol Chem; 2010 Jan; 285(3):1754-64. PubMed ID: 19920136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wild-type and mutant p53 differentially regulate NADPH oxidase 4 in TGF-β-mediated migration of human lung and breast epithelial cells.
    Boudreau HE; Casterline BW; Burke DJ; Leto TL
    Br J Cancer; 2014 May; 110(10):2569-82. PubMed ID: 24714748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
    Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc-mediated positive feedback loop.
    Zhao X; Shu D; Sun W; Si S; Ran W; Guo B; Cui L
    Cancer Commun (Lond); 2022 Oct; 42(10):987-1007. PubMed ID: 36002342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
    Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
    Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta induces CD44 cleavage that promotes migration of MDA-MB-435s cells through the up-regulation of membrane type 1-matrix metalloproteinase.
    Kuo YC; Su CH; Liu CY; Chen TH; Chen CP; Wang HS
    Int J Cancer; 2009 Jun; 124(11):2568-76. PubMed ID: 19243022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β-Dependent Growth Arrest and Cell Migration in Benign and Malignant Breast Epithelial Cells Are Antagonistically Controlled by Rac1 and Rac1b.
    Melzer C; von der Ohe J; Hass R; Ungefroren H
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28726720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexachlorobenzene modulates the crosstalk between the aryl hydrocarbon receptor and transforming growth factor-β1 signaling, enhancing human breast cancer cell migration and invasion.
    Miret N; Pontillo C; Ventura C; Carozzo A; Chiappini F; Kleiman de Pisarev D; Fernández N; Cocca C; Randi A
    Toxicology; 2016 Jul; 366-367():20-31. PubMed ID: 27519288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and antiestrogens alter breast cancer invasiveness by modulating the transforming growth factor-β signaling pathway.
    Goto N; Hiyoshi H; Ito I; Tsuchiya M; Nakajima Y; Yanagisawa J
    Cancer Sci; 2011 Aug; 102(8):1501-8. PubMed ID: 21564419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis.
    Ganapathy V; Ge R; Grazioli A; Xie W; Banach-Petrosky W; Kang Y; Lonning S; McPherson J; Yingling JM; Biswas S; Mundy GR; Reiss M
    Mol Cancer; 2010 May; 9():122. PubMed ID: 20504320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.